Geron | GERN - Pre Tax Profit

Geron reported $-42635000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Pre Tax Profit Change
Amgen AMGN:US USD 2.54B 364M
Cti Biopharma CTIC:US USD -17458000 1.75M
Cytokinetics CYTK:US USD -137380000 4.93M
Esperion Therapeutics ESPR:US USD -55487000 370K
Exelixis EXEL:US USD -31427000 123.47M
Genmab GEN:DC DKK 662M 2.61B
Geron GERN:US USD -42635000 1.58M
Gilead Sciences GILD:US USD 2.52B 357M
Macrogenics MGNX:US USD 12.8M 37.61M
Novartis NOVN:VX USD 3.86B 195M
Novavax NVAX:US USD -184509000 18.37M
YTE INCY:US USD 178.62M 401K